tm
Seeing Is Believing
tm
Seeing Is Believing
CMMB is currently covered by 1 analysts with an average price target of $25. This is a potential upside of $41.36 (802.53%) from yesterday's end of day stock price of $2.77.
Chemomab Therapeutics Ltd DRC's activity chart (see below) currently has 6 price targets and 10 ratings on display. The stock rating distribution of CMMB is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 32.86% with an average time for these price targets to be met of 106.86 days.
Highest price target for CMMB is $25, Lowest price target is $25, average price target is $25.
Most recent stock forecast was given by from OPPENHEIMER on 27-Aug-2025. First documented stock forecast 11-Mar-2019.
Currently out of the existing stock ratings of CMMB, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Jul-2024
$25
$23.41 (1472.33%)
$10
10 months 11 days ago
(27-Aug-2025)
2/5 (40%)
$21.52 (618.39%)
86
Buy Since 13-May-2024
$28
$26.22 (1473.03%)
$16
1 years 4 months 18 days ago
(20-Feb-2025)
0/2 (0%)
$20.92 (295.48%)
Hold
$7
3 years 1 months 1 days ago
(07-Jun-2023)
0/4 (0%)
$5.34 (321.69%)
Buy Since 11-Mar-2019
4 years 3 months 28 days ago
(10-Mar-2022)
1/2 (50%)
$154.24 (151.57%)
450
Buy Since 08-Dec-2021
$120
4 years 7 months ago
(08-Dec-2021)
0/1 (0%)
$88.44 (280.23%)
What is CMMB (Chemomab Therapeutics Ltd DRC) average time for price targets to be met?
Which analyst has the current highest performing score on CMMB (Chemomab Therapeutics Ltd DRC) with a proven track record?
Which analyst has the current lower performing score on CMMB (Chemomab Therapeutics Ltd DRC) with a proven track record?
Which analyst has the most public recommendations on CMMB (Chemomab Therapeutics Ltd DRC)?
Which analyst is the currently most bullish on CMMB (Chemomab Therapeutics Ltd DRC)?
Which analyst is the currently most reserved on CMMB (Chemomab Therapeutics Ltd DRC)?
